Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0015 | 0.0494 | 0.1295 |
Mycobacterium ulcerans | oxidoreductase | 0.0015 | 0.0494 | 0.5 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0015 | 0.0494 | 0.5 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0076 | 0.3809 | 1 |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0015 | 0.0494 | 0.5 |
Echinococcus multilocularis | 0.0015 | 0.0494 | 0.1295 | |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0076 | 0.3809 | 1 |
Brugia malayi | Myb-like DNA-binding domain containing protein | 0.0184 | 0.9706 | 1 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0022 | 0.0846 | 0.0871 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0494 | 0.0493 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0 | 0.5 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0015 | 0.0494 | 0.1295 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0076 | 0.3809 | 1 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0015 | 0.0494 | 0.5 |
Entamoeba histolytica | SWIRM domain protein | 0.0006 | 0 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0015 | 0.0494 | 0.1295 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0015 | 0.0494 | 0.1295 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0015 | 0.0494 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0015 | 0.0494 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0184 | 0.9706 | 0.9706 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0015 | 0.0494 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0015 | 0.0494 | 0.5 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0015 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0494 | 0.0493 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0015 | 0.0494 | 0.5 |
Brugia malayi | SWIRM domain containing protein | 0.0083 | 0.4161 | 0.4287 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0015 | 0.0494 | 0.5 |
Giardia lamblia | hypothetical protein | 0.0006 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.3809 | 0.3809 |
Mycobacterium ulcerans | monoamine oxidase | 0.0015 | 0.0494 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0015 | 0.0494 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0015 | 0.0494 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0006 | 0 | 0.5 |
Onchocerca volvulus | CoRest homolog | 0.019 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0015 | 0.0494 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0015 | 0.0494 | 0.1295 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0015 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0083 | 0.4161 | 0.4161 |
Loa Loa (eye worm) | hypothetical protein | 0.0076 | 0.3809 | 0.3809 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0015 | 0.0494 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0015 | 0.0494 | 1 |
Entamoeba histolytica | SWIRM domain protein | 0.0006 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0015 | 0.0494 | 0.0508 |
Mycobacterium ulcerans | dehydrogenase | 0.0015 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.0846 | 0.0845 |
Leishmania major | UDP-galactopyranose mutase | 0.0015 | 0.0494 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0015 | 0.0494 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0015 | 0.0494 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.